Resveratrol reduces vascular cell senescence through attenuation of oxidative stress by SIRT1/NADPH oxidase-dependent mechanisms

Journal of Nutritional Biochemistry

Volumn 23, Issue 11, 2012, Pages 1410-1416

  Tang, Yuhan ^a   Xu, Jian ^b   Qu, Wei ^c   Peng, Xiaolin ^a   Xin, Peng ^a   Yang, Xuefeng ^a   Ying, Chenjiang ^a   Sun, Xiufa ^a   Hao, Liping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Shen Zhen Center for Chronic Disease Control   (China)

^c BINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

NADPH oxidase; Resveratrol; SIRT1; Vascular cell senescence

Indexed keywords

REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; RESVERATROL; SIRTINOL; SIRTUIN 1; SUCROSE; VASCULAR CELL ADHESION MOLECULE 1;

AGING; ANIMAL EXPERIMENT; AORTA; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; LIPID DIET; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; SENESCENCE; WEIGHT GAIN;

ANIMALS; AORTA; BODY WEIGHT; CATTLE; CELL AGING; CELLS, CULTURED; DIET, HIGH-FAT; ENDOTHELIUM, VASCULAR; GLUCOSE; LIPIDS; MALE; NADPH OXIDASE; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SIRTUIN 1; STILBENES;

BOVINAE; RATTUS; RATTUS NORVEGICUS;

EID: 84862215866     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.08.008     Document Type: Article

References (65)

1. Minamino T., Komuro I. Vascular cell senescence: contribution to atherosclerosis. Circ Res 2007, 100:15-26.
2. Chen J., Goligorsky M.S. Premature senescence of endothelial cells: Methusaleh's dilemma. Am J Physiol Heart Circ Physiol 2006, 290:H1729-H1739.
3. Lakatta E.G., Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a "set up" for vascular disease. Circulation 2003, 107:139-146.
4. Carnethon M.R., Gidding S.S., Nehgme R., Sidney S., Jacobs D.R., Liu K. Cardiorespiratory fitness in young adulthood and the development of cardiovascular disease risk factors. JAMA 2003, 290:3092-3100.
5. Retnakaran R., Hanley A.J., Connelly P.W., Harris S.B., Zinman B. Cigarette smoking and cardiovascular risk factors among Aboriginal Canadian youths. CMAJ 2005, 173:885-889.
6. Labinskyy N., Csiszar A., Veress G., Stef G., Pacher P., Oroszi G., et al. Vascular dysfunction in aging: potential effects of resveratrol, an anti-inflammatory phytoestrogen. Curr Med Chem 2006, 13:989-996.
7. Finkel T. Radical medicine: treating ageing to cure disease. Nat Rev Mol Cell Biol 2005, 6:971-976.
8. Saito H., Hammond A.T., Moses R.E. The effect of low oxygen tension on the in vitro-replicative life span of human diploid fibroblast cells and their transformed derivatives. Exp Cell Res 1995, 217:272-279.
9. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002, 27:339-344.
10. Packer L., Fuehr K. Low oxygen concentration extends the lifespan of cultured human diploid cells. Nature 1977, 267:423-425.
11. Guzik T.J., West N.E., Black E., McDonald D., Ratnatunga C., Pillai R., et al. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res 2000, 86:E85-E90.
12. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007, 87:245-313.
13. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127:1109-1122.
14. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:337-342.
15. Valenzano D.R., Terzibasi E., Genade T., Cattaneo A., Domenici L., Cellerino A. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol 2006, 16:296-300.
16. Barger J.L., Kayo T., Vann J.M., Arias E.B., Wang J., Hacker T.A., et al. A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS One 2008, 3:e2264.
17. Fauconneau B., Waffo-Teguo P., Huguet F., Barrier L., Decendit A., Merillon J.M. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci 1997, 61:2103-2110.
18. Delmas D., Jannin B., Latruffe N. Resveratrol: preventing properties against vascular alterations and ageing. Mol Nutr Food Res 2005, 49:377-395.
19. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002, 82:47-95.
20. Kao C.L., Chen L.K., Chang Y.L., Yung M.C., Hsu C.C., Chen Y.C., et al. Resveratrol protects human endothelium from H(2)O(2)-induced oxidative stress and senescence via SirT1 activation. J Atheroscler Thromb 2010, 17:970-979.
21. Orimo M., Minamino T., Miyauchi H., Tateno K., Okada S., Moriya J., et al. Protective role of SIRT1 in diabetic vascular dysfunction. Arterioscler Thromb Vasc Biol 2009, 29:889-894.
22. Pearson K.J., Baur J.A., Lewis K.N., Peshkin L., Price N.L., Labinskyy N., et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 2008, 8:157-168.
23. Schilder Y.D., Heiss E.H., Schachner D., Ziegler J., Reznicek G., Sorescu D., et al. NADPH oxidases 1 and 4 mediate cellular senescence induced by resveratrol in human endothelial cells. Free Radic Biol Med 2009, 46:1598-1606.
24. Chow S.E., Hshu Y.C., Wang J.S., Chen J.K. Resveratrol attenuates oxLDL-stimulated NADPH oxidase activity and protects endothelial cells from oxidative functional damages. J Appl Physiol 2007, 102:1520-1527.
25. Orallo F., Alvarez E., Camina M., Leiro J.M., Gomez E., Fernandez P. The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol Pharmacol 2002, 61:294-302.
26. Hamilton C.A., Brosnan M.J., McIntyre M., Graham D., Dominiczak A.F. Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension 2001, 37:529-534.
27. Csiszar A., Ungvari Z., Edwards J.G., Kaminski P., Wolin M.S., Koller A., et al. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res 2002, 90:1159-1166.
28. Podlutsky A., Ballabh P., Csiszar A. Oxidative stress and endothelial dysfunction in pulmonary arteries of aged rats. Am J Physiol Heart Circ Physiol 2010, 298:H346-H351.
29. Tissenbaum H.A., Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 2001, 410:227-230.
30. Borra M.T., Smith B.C., Denu J.M. Mechanism of human SIRT1 activation by resveratrol. J Biol Chem 2005, 280:17187-17195.
31. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425:191-196.
32. Imai S., Armstrong C.M., Kaeberlein M., Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000, 403:795-800.
33. Ota H., Eto M., Kano M.R., Kahyo T., Setou M., Ogawa S., et al. Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway. Arterioscler Thromb Vasc Biol 2010, 30:2205-2211.
34. Zu Y., Liu L., Lee M.Y., Xu C., Liang Y., Man R.Y., et al. SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells. Circ Res 2010, 106:1384-1393.
35. Ying C.J., Xu J.W., Ikeda K., Takahashi K., Nara Y., Yamori Y. Tea polyphenols regulate nicotinamide adenine dinucleotide phosphate oxidase subunit expression and ameliorate angiotensin II-induced hyperpermeability in endothelial cells. Hypertens Res 2003, 26:823-828.
36. Morita Y., Naka T., Kawazoe Y., Fujimoto M., Narazaki M., Nakagawa R., et al. Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor alpha-induced cell death in fibroblasts. Proc Natl Acad Sci USA 2000, 97:5405-5410.
37. Fenton M., Barker S., Kurz D.J., Erusalimsky J.D. Cellular senescence after single and repeated balloon catheter denudations of rabbit carotid arteries. Arterioscler Thromb Vasc Biol 2001, 21:220-226.
38. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995, 92:9363-9367.
39. Zhou Z., Wang L., Song Z., Saari J.T., McClain C.J., Kang Y.J. Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress. Am J Pathol 2005, 166:1681-1690.
40. Harrison-Findik D.D., Schafer D., Klein E., Timchenko N.A., Kulaksiz H., Clemens D., et al. Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. J Biol Chem 2006, 281:22974-22982.
41. Yokoi T., Fukuo K., Yasuda O., Hotta M., Miyazaki J., Takemura Y., et al. Apoptosis signal-regulating kinase 1 mediates cellular senescence induced by high glucose in endothelial cells. Diabetes 2006, 55:1660-1665.
42. Dowling D.K., Simmons L.W. Reactive oxygen species as universal constraints in life-history evolution. Proc Biol Sci 2009, 276:1737-1745.
43. Keaney J.F. Oxidative stress and the vascular wall: NADPH oxidases take center stage. Circulation 2005, 112:2585-2588.
44. Hsich E., Segal B.H., Pagano P.J., Rey F.E., Paigen B., Deleonardis J., et al. Vascular effects following homozygous disruption of p47(phox): an essential component of NADPH oxidase. Circulation 2000, 101:1234-1236.
45. Lavigne M.C., Malech H.L., Holland S.M., Leto T.L. Genetic demonstration of p47phox-dependent superoxide anion production in murine vascular smooth muscle cells. Circulation 2001, 104:79-84.
46. Li J.M., Mullen A.M., Yun S., Wientjes F., Brouns G.Y., Thrasher A.J., et al. Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-alpha. Circ Res 2002, 90:143-150.
47. Matsuda T., Okamura K., Sato Y., Morimoto A., Ono M., Kohno K., et al. Decreased response to epidermal growth factor during cellular senescence in cultured human microvascular endothelial cells. J Cell Physiol 1992, 150:510-516.
48. Kumazaki T., Kobayashi M., Mitsui Y. Enhanced expression of fibronectin during in vivo cellular aging of human vascular endothelial cells and skin fibroblasts. Exp Cell Res 1993, 205:396-402.
49. Burrig K.F. The endothelium of advanced arteriosclerotic plaques in humans. Arterioscler Thromb 1991, 11:1678-1689.
50. Ross R., Wight T.N., Strandness E., Thiele B. Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol 1984, 114:79-93.
51. Sharpless N.E., Bardeesy N., Lee K.H., Carrasco D., Castrillon D.H., Aguirre A.J., et al. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 2001, 413:86-91.
52. Manna S.K., Mukhopadhyay A., Aggarwal B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 2000, 164:6509-6519.
53. Csiszar A., Smith K., Labinskyy N., Orosz Z., Rivera A., Ungvari Z. Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibition. Am J Physiol Heart Circ Physiol 2006, 291:H1694-H1699.
54. Markus M.A., Morris B.J. Resveratrol in prevention and treatment of common clinical conditions of aging. Clin Interv Aging 2008, 3:331-339.
55. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006, 5:493-506.
56. Zamora-Ros R., Andres-Lacueva C., Lamuela-Raventos R.M., Berenguer T., Jakszyn P., Martinez C., et al. Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort. Br J Nutr 2008, 100:188-196.
57. Csiszar A., Labinskyy N., Smith K., Rivera A., Orosz Z., Ungvari Z. Vasculoprotective effects of anti-tumor necrosis factor-alpha treatment in aging. Am J Pathol 2007, 170:388-398.
58. Francia P., delli Gatti C., Bachschmid M., Martin-Padura I., Savoia C., Migliaccio E., et al. Deletion of p66shc gene protects against age-related endothelial dysfunction. Circulation 2004, 110:2889-2895.
59. Sun D., Huang A., Yan E.H., Wu Z., Yan C., Kaminski P.M., et al. Reduced release of nitric oxide to shear stress in mesenteric arteries of aged rats. Am J Physiol Heart Circ Physiol 2004, 286:H2249-H2256.
60. Soccio M., Toniato E., Evangelista V., Carluccio M., De Caterina R. Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants. Eur J Clin Invest 2005, 35:305-314.
61. De Leo F.R., Ulman K.V., Davis A.R., Jutila K.L., Quinn M.T. Assembly of the human neutrophil NADPH oxidase involves binding of p67phox and flavocytochrome b to a common functional domain in p47phox. J Biol Chem 1996, 271:17013-17020.
62. Barry-Lane P.A., Patterson C., van der Merwe M., Hu Z., Holland S.M., Yeh E.T., et al. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest 2001, 108:1513-1522.
63. Mukai Y., Sato S. Polyphenol-containing azuki bean (Vigna angularis) seed coats attenuate vascular oxidative stress and inflammation in spontaneously hypertensive rats. J Nutr Biochem 2011, 22:16-21.
64. Donato A.J., Eskurza I., Silver A.E., Levy A.S., Pierce G.L., Gates P.E., et al. Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-kappaB. Circ Res 2007, 100:1659-1666.
65. Ota H., Akishita M., Eto M., Iijima K., Kaneki M., Ouchi Y. Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J Mol Cell Cardiol 2007, 43:571-579.